Rapid Micro Biosystems, Inc. (NASDAQ: RPID) reported Q1 EPS of ($0.32), $0.04 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $5.04 million versus the consensus estimate of $4.2 million.

GUIDANCE:

Rapid Micro Biosystems, Inc. sees FY2023 revenue of $22 million, versus the consensus of $22.088 million.

For earnings history and earnings-related data on Rapid Micro Biosystems, Inc. (RPID) click here.